Cargando…

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

BACKGROUND: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodeghiero, Francesco, Woszczyk, Dariusz, Slama, Borhane, Melikyan, Anait, Viallard, Jean-Francois, Ouaja, Rabye, Cisse, Ousmane Alfa, Sadoun, Alain, Salama, Abdulgabar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155829/ https://www.ncbi.nlm.nih.gov/pubmed/32300420 http://dx.doi.org/10.14740/jh385w

Ejemplares similares

IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double‐blind, multi‐center cross‐over non‐inferiority study vs Kiovig®—The LIME Study
por: Léger, Jean‐Marc, et al.
Publicado: (2018)

An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study
por: Nobile‐Orazio, Eduardo, et al.
Publicado: (2020)

A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency
por: Krivan, Gergely, et al.
Publicado: (2017)

Autoimmune Thrombocytopenia Complicated by EDTA- and/or Citrate-Dependent Pseudothrombocytopenia
por: Salama, Abdulgabar
Publicado: (2015)

Oxidative Stress Is Predominant in Female but Not in Male Patients with Autoimmune Thrombocytopenia
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)

Assessment timing and choice of outcome measure in determining treatment response in chronic inflammatory demyelinating polyneuropathy: A post hoc analysis of the PRISM trial
por: Rajabally, Yusuf A., et al.
Publicado: (2022)

Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
por: Kohn, Barbara, et al.
Publicado: (2016)

Erratum to: treatment of 5 dogs with immune-mediated thrombocytopenia using romiplostim
por: Kohn, Barbara, et al.
Publicado: (2016)

Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice
por: Depré, Fabian, et al.
Publicado: (2018)

Immune thrombocytopenia in myeloid and lymphoid clonal disorders: an intriguing association
por: Rodeghiero, Francesco
Publicado: (2021)

Just ten percent of the global terrestrial protected area network is structurally connected via intact land
por: Ward, Michelle, et al.
Publicado: (2020)

Clinically and/or Serologically Misleading Findings Surrounding Immune Haemolytic Anaemias
por: Salama, Abdulgabar
Publicado: (2015)

Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review
por: Salama, Abdulgabar
Publicado: (2015)

The tree of one percent
por: Dagan, Tal, et al.
Publicado: (2006)

The One-Percent Edge
por: Solovic, Susan
Publicado: (2018)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Effectiveness of 7.5 Percent Povidone Iodine in Comparison to 1 Percent Clotrimazole with Lignocaine in the Treatment of Otomycosis
por: Philip, Ajay, et al.
Publicado: (2013)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?
por: Viallard, Jean-François, et al.
Publicado: (2019)

Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
por: Khelif, Abderrahim, et al.
Publicado: (2018)

The Eighty Five Percent Rule for optimal learning
por: Wilson, Robert C., et al.
Publicado: (2019)

A Three Percent Structural Deficit Rule
por: Breuer, Christian
Publicado: (2022)

Percent Weightbearing in Foot and Ankle X-rays
por: Martella, Jessica, et al.
Publicado: (2022)

Advances in Management of the Stroke Etiology One-Percenters
por: Osteraas, Nicholas D., et al.
Publicado: (2023)

Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia
por: Vial, Guillaume, et al.
Publicado: (2019)

Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre
por: Mayer, Beate, et al.
Publicado: (2015)

A Low Percent Ethanol Method for Immobilizing Planarians
por: Stevenson, Claire G., et al.
Publicado: (2010)

CER adopts the 'one percent digital solidarity' principle
por: Garai, Atanu
Publicado: (2006)

The association of copy number variation and percent mammographic density
por: Atkinson, Elizabeth J, et al.
Publicado: (2015)

Can We Hang Our Hats on One Percent?
por: LeVasseur, Nathalie, et al.
Publicado: (2018)

Blood pressure and body fat percent in women with NMOSD
por: Chen, Xiaohong, et al.
Publicado: (2019)

Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
por: Arbach, O., et al.
Publicado: (2019)

The impact of COVID-19 Vaccination in Iranian elderly: 7 percent of all-cause deaths reduced by vaccinating 2 percent of population; letter to editor
por: Jambarsang, Sara, et al.
Publicado: (2022)

Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion
por: Lucchesi, Alessandro, et al.
Publicado: (2023)

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

Bringing the Tiger Back from the Brink—The Six Percent Solution
por: Walston, Joe, et al.
Publicado: (2010)

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients
por: Wood, Ruth A., et al.
Publicado: (2015)

Forty percent of hospitalizations after severe sepsis are potentially preventable
por: Prescott, HC, et al.
Publicado: (2014)

Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular Tissue
por: Ledger, Araminta E. W., et al.
Publicado: (2016)

Immigrants in the one percent: The national origin of top wealth owners
por: Keister, Lisa A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_463d0m5bfuhkpflci6vblet94r